Literature DB >> 17099778

TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.

Koichiro Kuwahara1, Yanggan Wang, John McAnally, James A Richardson, Rhonda Bassel-Duby, Joseph A Hill, Eric N Olson.   

Abstract

The heart responds to injury and chronic pressure overload by pathologic growth and remodeling, which frequently result in heart failure and sudden death. Calcium-dependent signaling pathways promote cardiac growth and associated changes in gene expression in response to stress. The calcium/calmodulin-dependent phosphatase calcineurin, which signals to nuclear factor of activated T cells (NFAT) transcription factors, serves as a transducer of calcium signals and is sufficient and necessary for pathologic cardiac hypertrophy and remodeling. Transient receptor potential (TRP) proteins regulate cation entry into cells in response to a variety of signals, and in skeletal muscle, expression of TRP cation channel, subfamily C, member 3 (TRPC3) is increased in response to neurostimulation and calcineurin signaling. Here we show that TRPC6 was upregulated in mouse hearts in response to activated calcineurin and pressure overload, as well as in failing human hearts. Two conserved NFAT consensus sites in the promoter of the TRPC6 gene conferred responsiveness to cardiac stress. Cardiac-specific overexpression of TRPC6 in transgenic mice resulted in heightened sensitivity to stress, a propensity for lethal cardiac growth and heart failure, and an increase in NFAT-dependent expression of beta-myosin heavy chain, a sensitive marker for pathologic hypertrophy. These findings implicate TRPC6 as a positive regulator of calcineurin-NFAT signaling and a key component of a calcium-dependent regulatory loop that drives pathologic cardiac remodeling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17099778      PMCID: PMC1635163          DOI: 10.1172/JCI27702

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  73 in total

1.  Myosin heavy chain isoform expression in the failing and nonfailing human heart.

Authors:  S Miyata; W Minobe; M R Bristow; L A Leinwand
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

Review 2.  Control of cardiac myosin heavy chain gene expression.

Authors:  E Morkin
Journal:  Microsc Res Tech       Date:  2000-09-15       Impact factor: 2.769

3.  A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

Authors:  U Delling; J Tureckova; H W Lim; L J De Windt; P Rotwein; J D Molkentin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1.

Authors:  M A Sussman; S Welch; A Walker; R Klevitsky; T E Hewett; R L Price; E Schaefer; K Yager
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

5.  Cardiac hypertrophy is not a required compensatory response to short-term pressure overload.

Authors:  J A Hill; M Karimi; W Kutschke; R L Davisson; K Zimmerman; Z Wang; R E Kerber; R M Weiss
Journal:  Circulation       Date:  2000-06-20       Impact factor: 29.690

6.  A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling.

Authors:  B Rothermel; R B Vega; J Yang; H Wu; R Bassel-Duby; R S Williams
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 7.  Abnormalities of calcium cycling in the hypertrophied and failing heart.

Authors:  S R Houser; V Piacentino; J Weisser
Journal:  J Mol Cell Cardiol       Date:  2000-09       Impact factor: 5.000

Review 8.  Transient receptor potential channels as molecular substrates of receptor-mediated cation entry.

Authors:  T Hofmann; M Schaefer; G Schultz; T Gudermann
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

9.  The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells.

Authors:  S Feske; R Draeger; H H Peter; K Eichmann; A Rao
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

10.  A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function.

Authors:  Stefan Feske; Yousang Gwack; Murali Prakriya; Sonal Srikanth; Sven-Holger Puppel; Bogdan Tanasa; Patrick G Hogan; Richard S Lewis; Mark Daly; Anjana Rao
Journal:  Nature       Date:  2006-04-02       Impact factor: 49.962

View more
  202 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 3.  Canonical TRP channels and mechanotransduction: from physiology to disease states.

Authors:  Amanda Patel; Reza Sharif-Naeini; Joost R H Folgering; Delphine Bichet; Fabrice Duprat; Eric Honoré
Journal:  Pflugers Arch       Date:  2010-05-21       Impact factor: 3.657

Review 4.  Emerging concepts for the role of TRP channels in the cardiovascular system.

Authors:  Rudi Vennekens
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

5.  Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.

Authors:  Tom Nijenhuis; Alexis J Sloan; Joost G J Hoenderop; Jan Flesche; Harry van Goor; Andreas D Kistler; Marinka Bakker; Rene J M Bindels; Rudolf A de Boer; Clemens C Möller; Inge Hamming; Gerjan Navis; Jack F M Wetzels; Jo H M Berden; Jochen Reiser; Christian Faul; Johan van der Vlag
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

6.  Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.

Authors:  D Brian Foster; Ting Liu; Kai Kammers; Robert O'Meally; Ni Yang; Kyriakos N Papanicolaou; C Conover Talbot; Robert N Cole; Brian O'Rourke
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

Review 7.  A Land of Controversy: Fibroblast Growth Factor-23 and Uremic Cardiac Hypertrophy.

Authors:  Jing-Fu Bao; Pan-Pan Hu; Qin-Ying She; Aiqing Li
Journal:  J Am Soc Nephrol       Date:  2020-06-11       Impact factor: 10.121

8.  Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules.

Authors:  Naohiro Yamaguchi; Asima Chakraborty; Daniel A Pasek; Jeffery D Molkentin; Gerhard Meissner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-18       Impact factor: 4.733

Review 9.  Cardiomyocyte Ca2+ homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction.

Authors:  Deborah Peana; Timothy L Domeier
Journal:  Curr Opin Pharmacol       Date:  2017-04-22       Impact factor: 5.547

10.  Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.

Authors:  Jung Woo Han; Young Ho Lee; Su-In Yoen; Joel Abramowitz; Lutz Birnbaumer; Min Goo Lee; Joo Young Kim
Journal:  Mol Cell Biochem       Date:  2016-08-13       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.